MedWatch

Lundbeck divests headquarter in million dollar agreement

The Danish company Lundbeck has entered a conditional agreement about divesting two buildings on the company’s site in Valby, Copenhagen. Lundbeck will receive a payment of DKK 378 million (about USD 55.6 million) and expects the sale to have a positive effect on its financial guidance.

Photo: Jens Dresling/Ritzau/arkiv

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

FDA vil lette vejen til markedet for medicin mod Alzheimers

De amerikanske lægemiddelmyndigheder vil lempe kravene til godkendelse af lægemidler mod Alzheimers, fordi forskning viser, at sygdommen indtræder tidligere end hidtil antaget. Lægemiddeludviklingen og godkendelse heraf derfor skal tilpasses derefter, mener FDA-boss Scott Gottlieb.

Related articles